Dubai: M42, a global health leader leveraging technology, AI, and genomics, has partnered with US-based 10X Health and UK-based REVIV Global to launch 10XREVIV, a pioneering initiative aimed at transforming precision health, nutrition, and longevity in the region.
The collaboration will introduce a first-of-its-kind Precision Nutrition System to the Middle East, combining genetic insights, blood biomarkers, and nutritional science through proprietary artificial intelligence to deliver hyper-personalized health optimization at scale.
At the core of this venture is the 10X Precision Nutrition System, a patented life-sciences platform developed over more than a decade by leading biotechnologists and data scientists. The system analyzes up to 20 million genetic variations with 99.97 percent accuracy, integrating DNA, blood chemistry, and lifestyle inputs to generate a secure, 400+-page digital health report. The report provides actionable insights into nutrient absorption, metabolic efficiency, inflammation, immune function, cardiovascular health, and longevity pathways.
Leveraging these insights, 10XREVIV offers a suite of precision-based interventions, including:
- 10X Precision Supplements – micro-bead formulations with up to 22 micronutrients, optimized for genetic compatibility and bioavailability.
- 10X Precision Weight Management Solutions – targeted carbohydrate and fat modulators calibrated to individual metabolic and genetic profiles.
- Precision IV Therapy – globally patented IV protocols guided by genetic data, administered exclusively through certified medical facilities.
The partnership also plans to launch a Precision Longevity flagship clinic, conduct a randomized control trial on the impact of IV nutrition on Type 2 Diabetes, and introduce a Precision Nutrition training curriculum for medical practitioners, enabling them to interpret genetic data and apply it clinically.
Albarah El Khani, COO of Integrated Health Solutions at M42, stated that, “At M42, we are committed to redefining healthcare delivery by integrating AI, data, and life sciences to unlock human potential. Our partnership with 10X Health and REVIV Global marks a significant step toward predictive and preventive care, where genetic and biomarker insights directly inform how we nourish, restore, and optimize the human body.”
Brandon Dawson, Co-Founder and CEO of 10X Health, added that, “Partnering with M42 & REVIV Global allows us to bring the 10X Precision System to one of the most forward-thinking healthcare ecosystems in the world. Together, we are setting a new global benchmark for human optimization, merging science, technology, and clinical application.”
Sarah Lomas, CEO and Founder of REVIV Global, commented that, “This alliance elevates our vision by combining cutting-edge genetics, AI-driven nutrition, and world-class clinical delivery. We are excited to bring these advanced solutions to the Middle East and help define a future of longevity and precision health.”
MOST READ | Borouge launches 1st UAE-made LDPE for healthcare
